1,428
Views
8
CrossRef citations to date
0
Altmetric
Editorial

Highly different risk estimates for atypical femoral fracture with use of bisphosphonates – debate must be allowed!

Pages 319-320 | Published online: 20 Aug 2012
 

Disclosure

PA has shares in a company (Addbio AB) trying to commercialize bisphosphonate coatings for implants. PA also has received consulting reimbursement and grants from Eli Lilly & Co and from Amgen.